Abstract
Rationale and objectives
Although clozapine is effective in treating schizophrenia, it is associated with adverse side effects including weight gain and metabolic syndrome. Despite this, the role of clozapine on feeding behaviour and food intake has not been thoroughly characterised. Clozapine has a broad pharmacological profile, with affinities for several neurotransmitter receptors, including serotonin (5-hydroxytriptamine, 5-HT) and histamine. Given that the serotonin 5-HT2C receptor and histaminergic H1 receptor are involved in aspects of feeding behaviour, the effect of clozapine on feeding may be linked to its action at these receptors.
Methods
We assessed, in rats, the effect of acute and subchronic administration of clozapine on responding for food under a progressive ratio (PR) schedule under conditions of food restriction and satiety. We also examined the effect of antagonists of the serotonin 5-HT2C and histaminergic H1 receptors on the same schedule. Clozapine reliably increased responding for food, even when rats had ad libitum access to food. The effect of clozapine on responding for food was reproduced by combined (but not individual) antagonism of the serotonin 5-HT2C and histaminergic H1 receptors.
Conclusion
These findings show that clozapine enhances the motivation to work for food, that this effect is stable over repeated testing, and is independent of hunger state of the animal. This effect may relate to a combined action of clozapine at the serotonin 5-HT2C and histaminergic H1 receptors.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Abela AR, Li Z, Lê AD, Fletcher PJ (2018) Clozapine reduces nicotine self-administration, blunts reinstatement of nicotine-seeking but increases responding for food. Addict Biol. https://doi.org/10.1111/adb.12619
Albaugh VL, Henry CR, Bello NT et al (2006) Hormonal and metabolic effects of olanzapine and clozapine related to body weight in rodents. Obesity. https://doi.org/10.1038/oby.2006.6
Antelman SM, Black CA, Rowland NE (1977) Clozapine induces hyperphagia in undeprived rats. Life Sci. https://doi.org/10.1016/0024-3205(77)90154-0
Baldessarini RJ, Centorrino F, Flood JG, Volpicelli SA, Huston-Lyons D, Cohen BM (1993) Tissue concentrations of clozapine and its metabolites in the rat. Neuropsychopharmacology 9:117–124. https://doi.org/10.1038/npp.1993.50
Baptista T, Mata A, Teneud L et al (1993) Effects of long-term administration of clozapine on body weight and food intake in rats. Pharmacol Biochem Behav. https://doi.org/10.1016/0091-3057(93)90084-7
Benarroch L, Kowalchuk C, Wilson V, Teo C, Guenette M, Chintoh A, Nesarajah Y, Taylor V, Selby P, Fletcher P, Remington GJ, Hahn MK (2016) Atypical antipsychotics and effects on feeding: from mice to men. Psychopharmacology 233:2629–2653. https://doi.org/10.1007/s00213-016-4324-8
Benvenga MJ, David Leander J (1997) Increased food consumption by clozapine, but not by olanzapine, in satiated rats. Drug Dev Res
Berridge KC (1991) Modulation of taste affect by hunger, caloric satiety, and sensory-specific satiety in the rat. Appetite. https://doi.org/10.1016/0195-6663(91)90036-R
Bonhaus DW, Weinhardt KK, Taylor M et al (1997) RS-102221: a novel high affinity and selective, 5-HT(2C) receptor antagonist. Neuropharmacology. https://doi.org/10.1016/S0028-3908(97)00049-X
Bymaster FP, Calligaro DO, Falcone JF, Marsh RD, Moore NA, Tye NC, Seeman P, Wong DT (1996) Radioreceptor binding profile of the atypical antipsychotic olanzapine. Neuropsychopharmacology 14:87–96. https://doi.org/10.1016/0893-133X(94)00129-N
Choi S, DiSilvio B, Unangst J, Fernstrom JD (2007) Effect of chronic infusion of olanzapine and clozapine on food intake and body weight gain in male and female rats. Life Sci. https://doi.org/10.1016/j.lfs.2007.08.009
Cilia J, Piper DC, Upton N, Hagan JJ (2001) Clozapine enhances breakpoint in common marmosets responding on a progressive ratio schedule. Psychopharmacology 155:135–143. https://doi.org/10.1007/s002130100682
Cooper GD, Harrold JA, Halford JCG, Goudie AJ (2008) Chronic clozapine treatment in female rats does not induce weight gain or metabolic abnormalities but enhances adiposity: implications for animal models of antipsychotic-induced weight gain. Prog Neuro-Psychopharmacol Biol Psychiatry. https://doi.org/10.1016/j.pnpbp.2007.09.012
Dipasquale S, Pariante CM, Dazzan P et al (2013) The dietary pattern of patients with schizophrenia: a systematic review. J Psychiatr Res
Fletcher PJ, Sinyard J, Higgins GA (2010) Genetic and pharmacological evidence that 5-HT2C receptor activation, but not inhibition, affects motivation to feed under a progressive ratio schedule of reinforcement. Pharmacol Biochem Behav 97:170–178. https://doi.org/10.1016/j.pbb.2010.07.002
Galistu A, Modde C, Pireddu MC, Franconi F, Serra G, D’Aquila PS (2011) Clozapine increases reward evaluation but not overall ingestive behaviour in rats licking for sucrose. Psychopharmacology 216:411–420. https://doi.org/10.1007/s00213-011-2237-0
Gebhart S, Haberhausen M, Krieg J-C et al (2007) Clozapine/olanzapine-induced recurrence or deterioration of binge eating-related eating disorders. J Neural Transm. https://doi.org/10.1007/s00702-007-0663-2
Goudie AJ, Smith JA (1999) Discriminative Stimulus Properties of Antipsychotics. Pharmacology Biochemistry and Behavior 64 (2):193-201
Goudie AJ, Cooper GD, Cole JC, Sumnall HR (2007) Cyproheptadine resembles clozapine in vivo following both acute and chronic administration in rats. J Psychopharmacol. https://doi.org/10.1177/0269881107067076
Hartfield AW, Moore NA, Clifton PG (2003) Serotonergic and histaminergic mechanisms involved in intralipid drinking? Pharmacol Biochem Behav 76:251–258. https://doi.org/10.1016/S0091-3057(03)00221-1
Kaempf GL, Porter JH (1987) Differential effects of pimozide and clozapine on schedule-controlled and scheduled-induced behaviors after acute and chronic administration. J Pharmacol Exp Ther
Kaur G, Kulkarni SK (2002) Studies on modulation of feeding behavior by atypical antipsychotics in female mice. Prog Neuro Psychopharmacol Biol Psychiatry. https://doi.org/10.1016/S0278-5846(01)00266-4
Kennett GA, Wood MD, Bright F et al (1997) SE 242084, a selective and brain penetrant 5-HT(2C) receptor antagonist. Neuropharmacology. https://doi.org/10.1016/S0028-3908(97)00038-5
Kim SF, Huang AS, Snowman AM, Teuscher C, Snyder SH (2007) Antipsychotic drug-induced weight gain mediated by histamine H1 receptor-linked activation of hypothalamic AMP-kinase. Proc Natl Acad Sci 104:3456–3459. https://doi.org/10.1073/pnas.0611417104
Kirk SL, Glazebrook J, Grayson B, Neill JC, Reynolds GP (2009) Olanzapine-induced weight gain in the rat: role of 5-HT2C and histamine H1 receptors. Psychopharmacology 207:119–125. https://doi.org/10.1007/s00213-009-1639-8
Kluge M, Schuld A, Himmerich H et al (2007) Clozapine and olanzapine are associated with food craving and binge eating: results from a randomized double-blind study. J Clin Psychopharmacol. https://doi.org/10.1097/jcp.0b013e31815a8872
Leadbetter R, Shutty M, Pavalonis D, Vieweg V, Higgins P, Downs M (1992) Clozapine-induced weight gain: prevalence and clinical relevance. Am J Psychiatry 149:68–72. https://doi.org/10.1176/ajp.149.1.68
Lecklin A, Tuomisto L (1998) The blockade of H1 receptors attenuates the suppression of feeding and diuresis induced by inhibition of histamine catabolism. Pharmacol Biochem Behav. https://doi.org/10.1016/S0091-3057(97)00465-6
Lee MD, Clifton PG (2002) Meal patterns of free feeding rats treated with clozapine, olanzapine, or haloperidol. Pharmacol Biochem Behav. https://doi.org/10.1016/S0091-3057(01)00630-X
Levin ED, Slade S, Wells C, Pruitt M, Cousins V, Cauley M, Petro A, Hampton D, Rose J (2011) Histamine H 1 antagonist treatment with pyrilamine reduces nicotine self-administration in rats. Eur J Pharmacol 650:256–260. https://doi.org/10.1016/j.ejphar.2010.10.013
Li M (2016) Antipsychotic-induced sensitization and tolerance: behavioral characteristics, developmental impacts, and neurobiological mechanisms. J Psychopharmacol. https://doi.org/10.1177/0269881116654697
Loh EA, Fitch T, Gary V, Roberts DCS (1992) Clozapine increases breaking points on a progressive-ratio schedule reinforced by intravenous cocaine. Pharmacol Biochem Behav 42:559–562. https://doi.org/10.1016/0091-3057(92)90156-A
Miller DD (2000) Review and management of clozapine side effects. J Clin Psychiatry 61:14–19
Mobini S, Chiang TJ, Ho MY, Bradshaw CM, Szabadi E (2000) Comparison of the effects of clozapine, haloperidol, chloropromazine and d-amphetamine on performance on a time-constrained progressive ratio schedule and on locomotor behaviour in the rat. Psychopharmacology 152:47–54. https://doi.org/10.1007/s002130000486
Natesan S, Reckless GE, Barlow KBL, Nobrega JN, Kapur S (2008) Amisulpride the “atypical” atypical antipsychotic - comparison to haloperidol, risperidone and clozapine. Schizophr Res 105:224–235. https://doi.org/10.1016/j.schres.2008.07.005
Olarte-Sánchez CM, Valencia Torres L, Body S, Cassaday HJ, Bradshaw CM, Szabadi E, Goudie AJ (2012) A clozapine-like effect of cyproheptadine on progressive ratio schedule performance. J Psychopharmacol 26:857–870. https://doi.org/10.1177/0269881111408961
Ookuma K, Yoshimatsu H, Sakata T et al (1989) Hypothalamic sites of neuronal histamine action on food intake by rats. Brain Res. https://doi.org/10.1016/0006-8993(89)90244-8
Richelson E, Souder T (2000) Binding of antipsychotic drugs to human brain receptors. Life Sci 68:29–39. https://doi.org/10.1016/S0024-3205(00)00911-5
Roberts DCS, Loh EA, Vickers G (1989) Self-administration of cocaine on a progressive ratio schedule in rats: dose-response relationship and effect of haloperidol pretreatment. Psychopharmacology 97 (4):535-538
Sakata T, Fukagawa K, Ookuma K et al (1988a) Modulation of neuronal histamine in control of food intake. Physiol Behav. https://doi.org/10.1016/0031-9384(88)90316-2
Sakata T, Ookuma K, Fukagawa K et al (1988b) Blockade of the histamine H 1 -receptor in the rat ventromedial hypothalamus and feeding elicitation. Brain Res. https://doi.org/10.1016/0006-8993(88)91423-0
Theisen FM, Linden A, Konig IR et al (2003) Spectrum of binge eating symptomatology in patients treated with clozapine and olanzapine. J Neural Transm 110:111–121. https://doi.org/10.1007/s00702-002-0792-6
Zhang Z, Rickard JF, Asgari K, Body S, Bradshaw CM, Szabadi E (2005) Quantitative analysis of the effects of some “atypical” and “conventional” antipsychotics on progressive ratio schedule performance. Psychopharmacology 179:489–497. https://doi.org/10.1007/s00213-004-2049-6
Acknowledgements
Andrew R. Abela was supported by fellowships from the Centre for Addiction and Mental Health (CAMH) and the Canadian Institutes of Health Research (CIHR).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that they have no conflict of interest.
Additional information
Publisher’s note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Abela, A.R., Ji, X.D., Li, Z. et al. Clozapine reliably increases the motivation for food: parsing the role of the 5-HT2c and H1 receptors. Psychopharmacology 237, 957–966 (2020). https://doi.org/10.1007/s00213-019-05425-7
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00213-019-05425-7